XML 34 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Balance Sheets (USD $)
Sep. 30, 2014
Dec. 31, 2013
Current assets    
Cash and cash equivalents $ 23,639,558 $ 1,818,317
Prepaid expenses 583,539 852
Total current assets 24,223,097 1,819,169
Equipment, net 35,566 3,232
In-process research and development 34,200,000 19,000,000
Goodwill 14,869,399 7,918,387
Deferred public offering costs   433,998
Total assets 73,328,062 29,174,786
Current liabilities    
Accounts payable 942,228 522,981
Accrued expenses and other current liabilities 850,424 815,239
Accrued collaborative expenses 1,386,493  
Convertible promissory notes   58,270
Derivative liability   10,093
Total current liabilities 3,179,145 1,406,583
Deferred taxes 13,433,760 7,588,600
Total liabilities 16,612,905 8,995,183
Commitments and contingencies      
Stockholders’ equity    
Preferred stock; $.0001 par value; 100,000,000 shares authorized; none issued or outstanding as of September 30, 2014 and December 31, 2013, respectively      
Common stock; $.0001 par value; 125,000,000 shares authorized; 18,439,482 and 6,112,738 shares issued and outstanding as of September 30, 2014 and December 31, 2013, respectively 1,844 611
Additional paid-in capital 124,002,381 38,008,783
Accumulated deficit (67,289,068) (17,829,791)
Total stockholders’ equity 56,715,157 20,179,603
Total liabilities and stockholders’ equity $ 73,328,062 $ 29,174,786